Table 3 Seroprevalence of B. burgdorferi antibodies in dogs from Canada using the IDEXX Snap test in 2008 [73] and 2013–2014 [72], compared to human incidence of reported LD cases in Canadian provinces (mean for 2013–2014 [13]). 95% CI = 95% confidence intervals. Province abbreviations are BC British Columbia, AB Alberta, SK Saskatchewan, MB Manitoba, ON Ontario, QC Quebec, NB New Brunswick, NS Nova Scotia, PEI Prince Edward Island
From: What is the real number of Lyme disease cases in Canada?
Province | 2008 canine seroprevalence data (% and 95 CI) | 2013–2014 canine seroprevalence data (% and 95 CI) [65] | Mean incidence (2013–2014) of human Lyme disease in Canadian provinces |
|---|---|---|---|
BC | 0 (0–0.09) |  | 0.10 |
AB | 0.17 (<  0.01–0.64) |  | 0.35 |
SK | 0.34 (<  0.01–1.24) | 0.54 (0.01–3.30) | 0.05 |
MB | 1.90 (1.70–2.15) | 2.4 (2.1–2.7) | 2.5 |
ON | 0.47 (0.42–0.53) | 2.3 (2.2–2.4) | 2.0 |
QC | 0.57 (0.45–0.71) | 2.8 (2.6–3.0) | 1.6 |
NB | 0.66 (0.01–3.63) | 3.7 (2.9–4.7) | 0.7 |
NS | 2.15 (1.21–3.52) | 15.7 (11.4–21.3) | 14.1 |
PEI | 10.0 (2.11–26.52) |  | 0 |
Total for Canada | 0.72 (0.67–0.78) | 2.46 (2.37–2.55) | 1.7 |